Renee Aguiar-Lucander

Renee Aguiar-Lucander is a seasoned professional with over 20 years of experience in company management and strategic development, specializing in US and European direct investments, deal structuring, and execution.

With a background in healthcare and technology sectors, she brings a wealth of expertise in these areas. Renee has served on numerous boards of private and public enterprises in Europe and the US, providing valuable insights and leadership.

Her educational qualifications include an MBA in Business Administration and Management from INSEAD, and a BA in Accounting and Finance from Stockholm School of Economics.

Throughout her career, Renee has held key positions such as Chief Executive Officer at Calliditas Therapeutics AB, Managing Partner at Positive Capital Partners, Director at RAL Capital Ltd, CEO at Pharmalink AB, and Partner at Omega Fund Management, among others.

She also has experience in fund-related operations as a Chief Operating Officer, dealing with regulatory and compliance matters effectively.

Renee's professional journey showcases her diverse roles in prominent organizations such as Lehman Brothers, 3i Group plc, BT Alex. Brown, and Alex. Brown & Sons, indicating her extensive industry knowledge and leadership capabilities.